Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone

Hasonló tételek

• Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis
  Szerző: Miehlke Stephan, et al.
  Megjelent: (2018)
• Novel extended release budesonide formulation for treatment of ulcerative colitis
  Szerző: Farkas Klaudia, et al.
  Megjelent: (2014)
• Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
  Szerző: Sands Bruce E., et al.
  Megjelent: (2019)
• Efficacy and safety of adalimumab in ulcerative colitis refractory to conventional therapy in routine clinical practice
  Szerző: Bálint Anita, et al.
  Megjelent: (2016)
• Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn’s Disease A Retrospective, Multicentre Study /
  Szerző: Farkas Bernadett, et al.
  Megjelent: (2024)